The Department of Health – Abu Dhabi (DoH) has partnered with Abbott, a leading global healthcare company, to establish a local pharmaceutical manufacturing facility in Abu Dhabi. This collaboration aims to enhance the local production of medicines, reflecting a significant step in improving healthcare accessibility and sustainability in the region.

The new facility is expected to produce a range of essential medications, contributing to the local economy and creating job opportunities. The partnership underscores the commitment of both DoH and Abbott to promote healthcare innovation and ensure a reliable supply of pharmaceuticals in the emirate.

Officials from the Department of Health stated that this initiative aligns with Abu Dhabi’s broader strategy to strengthen its healthcare sector and reduce dependency on imported medicines. Abbott aims to leverage its expertise in the healthcare industry to meet the growing demand for high-quality pharmaceuticals in the region.